Pharmacy
Hello, Suzanne Dixon
Manage E-mail  |  Logout

Article ID

Home
General Pharmacy
Messages (38)
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Management
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Messages

Need hemophilia CME? Here’s the latest, straight from ISTH 2009 in Boston, with expert commentary on the topics you...
Victoria Luken, MDLinx CME
FDA Update: Bevacizumab + Interferon Alfa Approved for Renal Cell Carcinoma
Tracy Hampton, PhD, MDLinx Oncology
Congress Proposes SGR Fix
Roberta Buell, MBA, Sausalito Healthcare Partners
  See all

Articles: Dosing



Latest (1) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Safety of Double-Dose Transdermal Scopolamine
Pharmacotherapy, 08/27/09
Sponsor
Stepped-dose efavirenz reduces neuropsychiatric events
American Pharmacists Association, 08/26/09    Free full text
Aripiprazole: Dose-Response Relationship in Schizophrenia and Schizoaffective Disorder
CNS Drugs, 08/26/09
Argatroban Dosage Requirements and Outcomes in Intensive Care versus Non–Intensive Care Patients
Pharmacotherapy, 08/26/09
Rituximab in combination with high-dose methylprednisolone for the treatment of chronic lymphocytic leukemia
Leukemia, 08/26/09
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
European Heart Journal, 08/25/09
In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d][1,2,4]triazine (MRK-016), a GABAA receptor alpha 5 subtype-selective inverse agonist
Journal of Pharmacology and Experimental Therapeutics, 08/25/09
The effect of high dose of N-acetylcysteine in lupus nephritis: a case report and literature review
Journal of Clinical Pharmacy and Therapeutics, 08/24/09
Low-dose oral midazolam reduces fear and distress during needle procedures in children with cancer
Pediatric Blood & Cancer, 08/21/09
Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors
Journal of Clinical Pharmacy and Therapeutics, 08/21/09
A phase I trial assessing the safety, tolerability, pharmacokinetic and pharmacodynamic characteristics of single-dose Auron Misheil therapy in healthy male subjects
Journal of Clinical Pharmacy and Therapeutics, 08/21/09
Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin
Current Medical Research and Opinion, 08/20/09
Forest Announces Phase IIb Study Results For Oglemilast in Chronic Obstructive Pulmonary Disease
Forest Laboratories, 08/20/09    Free full text
Investigation of coated whey protein/alginate beads as sustained release dosage form in simulated gastrointestinal environment
Drug Development and Industrial Pharmacy, 08/20/09
Sitagliptin 100mg daily effect on DPP-4 inhibition and compound-specific glycemic improvement
Current Medical Research and Opinion, 08/20/09
Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference
Current Medical Research and Opinion, 08/20/09
Fda accepts drug application for miconazole lauriad to treat oropharyngeal candidiasis
Par Pharmaceutical, 08/20/09
Gastric mucosal injury in systemic lupus erythematosus patients receiving pulse methylprednisolone therapy
British Journal of Clinical Pharmacology, 08/19/09
Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: A phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period
Clinical Therapeutics, 08/19/09
Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension
Core Evidence, 08/18/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
250 Available Pages
First    Prev    5      6      7      8      9      10      11      12      13      14      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Pharmacy Articles Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.